Tellgen Corporation (300642)

Overview

Tellgen Corporation, established in 2003 and headquartered in Shanghai, China, operates within the biotechnology field with a focus on the research, development, manufacturing, and distribution of In Vitro Diagnostic (IVD) products. Catering to both the domestic and international markets, Tellgen’s portfolio is aimed at addressing a variety of medical diagnostics needs including cancer, cardiovascular diseases, autoimmune disorders, and infectious diseases such as COVID-19. The company's expertise in diagnostic reagents and testing instruments underscores its commitment to advancing healthcare solutions globally.

Products and Services

• Tumor Markers

  Tellgen offers a range of diagnostic kits for the identification of various tumor markers, aiding in the early detection and management of cancer.

• Cervical Cancer and HPV Testing Kits

  Specialized kits designed for the screening and detection of Human Papillomavirus (HPV) and cervical cancer, contributing to effective women's health management.

• Y Chromosome Microdeletions Test Kits

  These kits are geared towards the analysis of Y chromosome microdeletions, which are significant in studying male infertility.

• Autoimmune

  The company produces diagnostic solutions for the detection of various autoimmune diseases, helping in the diagnosis and monitoring of these conditions.

• Cardiovascular and Inflammation

  Tellgen's offerings include kits for the assessment of cardiovascular health and inflammation markers, key in the prevention and management of cardiovascular diseases.

• Biochemistry Kits

  Comprehensive kits for biochemical analysis, supporting a wide range of diagnostic applications in clinical laboratories.

• DNA Methylation Testing Kits

  These kits are designed for the detection of DNA methylation patterns, essential for understanding and diagnosing various genetic and oncological conditions.

• Molecular Detection of COVID-19 and Others

  In response to the global pandemic, Tellgen has developed testing kits for the molecular detection of COVID-19, alongside other infectious diseases, ensuring rapid and accurate diagnostics.

• Diagnostic Reagents/Testing Instruments and Assembly Lines

  Beyond individual testing kits, Tellgen Corporation provides comprehensive solutions that include diagnostic reagents, testing instruments, and assembly lines for laboratory setups.